Carbone K M
FDA/CBER, HFM 460, 8800 Rockville Pike, Bethesda, MD 20892, USA.
Clin Microbiol Rev. 2001 Jul;14(3):513-27. doi: 10.1128/CMR.14.3.513-527.2001.
The biology of Borna disease virus (BDV) strongly supports the likelihood of human infection with BDV or a variant of BDV. Thus far, the evidence supporting BDV infection in humans has initiated much controversy among basic and clinical scientists; only time and additional research will support or refute the hypothesis of human BDV infection. Until an assay of acceptable specificity and sensitivity has been developed, validated, and used to document human BDV infection, scientists cannot reasonably begin to associate BDV infection with specific disease syndromes. Clinical studies seeking causal associations between BDV infection and specific diseases must ensure the proper identification of the BDV infection status of patients and control subjects by using a validated, highly sensitive, and highly specific assay (or series of assays). For clinical studies, a highly sensitive "screening" test followed by a highly specific confirmatory test will be of significant benefit. Although it is possible to formulate hypotheses about the clinical outcomes of human BDV infection based on animal model work, to date no human disease has been causally linked to human BDV infection. Scientists all over the world are actively pursuing these issues, and with continuing advances in clinical and basic BDV research, the answers cannot be far away.
博尔纳病病毒(BDV)的生物学特性有力地支持了人类感染BDV或BDV变体的可能性。迄今为止,支持人类感染BDV的证据在基础科学家和临床科学家之间引发了诸多争议;只有时间和更多研究才能支持或反驳人类BDV感染的假说。在开发、验证并用于记录人类BDV感染的具有可接受特异性和敏感性的检测方法出现之前,科学家无法合理地开始将BDV感染与特定疾病综合征联系起来。寻求BDV感染与特定疾病之间因果关联的临床研究必须通过使用经过验证的、高度敏感且高度特异的检测方法(或一系列检测方法)来确保正确识别患者和对照受试者的BDV感染状态。对于临床研究而言,先进行高灵敏度的“筛查”检测,再进行高特异性的确认检测将大有裨益。尽管基于动物模型研究有可能对人类BDV感染的临床结果提出假说,但迄今为止,尚无人类疾病被证实与人类BDV感染存在因果关系。世界各地的科学家都在积极研究这些问题,随着BDV临床和基础研究的不断进展,答案已为期不远。